Product Information
FIDAXOMICIN 200 MG TABLET is a generic product labeled by Apotex Corp., priced at $90.5046 per EA under NDC 60505483302. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Feb 2, 2026. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Apotex Corp.NDC
60505483302
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FIDAXOMICINApproval Type
Generic (ANDA)
FDA Application
ANDA219559FDA Approved
2/2/2026
TE Code
AB
On Market Since
2/2/2026
Pharmacological Classes
Price Statistics
The NADAC for FIDAXOMICIN 200 MG TABLET has been published 32 times since Feb 25, 2026, and over the history we have for it it has declined 52.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $90.5046 per EA |
|---|---|
| All-time high | $193.6654 (Apr 15, 2026) |
| All-time low | $90.5046 (Sep 23, 2026) |
| 52-week high | $193.6654 |
| 52-week low | $90.5046 |
| Median price | $115.0874 |
| Average price | $132.7233 |
| Largest weekly change | -23.1% (Jun 17, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fidaxomicin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fidaxomicin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FIDAXOMICIN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FIDAXOMICIN 200 MG TABLET, manufactured by Apotex Corp., is $90.5046 per EA (NDC 60505483302), effective Sep 30, 2026.
How has the price of FIDAXOMICIN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for FIDAXOMICIN 200 MG TABLET has declined 52.7%. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for FIDAXOMICIN 200 MG TABLET?
Since Feb 25, 2026, the NADAC for FIDAXOMICIN 200 MG TABLET has ranged from a low of $90.5046 (Sep 23, 2026) to a high of $193.6654 (Apr 15, 2026), with a median of $115.0874 per EA.
Are there cheaper alternatives to FIDAXOMICIN 200 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FIDAXOMICIN 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FIDAXOMICIN 200 MG TABLET?
FIDAXOMICIN 200 MG TABLET (NDC 60505483302) is labeled by Apotex Corp., and CMS classifies it as a generic product.